| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 08/17/2011 | CN102151262A Compounds for the treatment of metabolic disorders |
| 08/17/2011 | CN102151261A Use of [3.2.0] heterocyclic compounds and analogs thereof for the treatment of cancer, inflammation and infectious diseases |
| 08/17/2011 | CN102151254A Jiekang disinfectant |
| 08/17/2011 | CN102150959A Air-permeable protective face fabric |
| 08/17/2011 | CN102150850A Debitterized pomelo peel processed powder |
| 08/17/2011 | CN102150773A Polygonatum odoratum and aloe compound capsule |
| 08/17/2011 | CN101862384B External medicament for treating leucoderma |
| 08/17/2011 | CN101843819B Chinese medicament for treating psoriasis |
| 08/17/2011 | CN101843735B Chinese medicament for treating psoriasis |
| 08/17/2011 | CN101843711B Chinese medicament for treating ichthyosis |
| 08/17/2011 | CN101780194B Medicament for treating bedsore in clinical care |
| 08/17/2011 | CN101708253B Prickly heat powder |
| 08/17/2011 | CN101703657B External preparation for treating verruca vulgaris |
| 08/17/2011 | CN101703604B Medicament for treating dermatophytosis |
| 08/17/2011 | CN101703603B External-use ointment for treating empyrosis and preparation method thereof |
| 08/17/2011 | CN101698045B Traditional Chinese medicine powder for treating psoriasis and preparation method |
| 08/17/2011 | CN101670019B Complex preparation having radiation-resisting and eyesight-protecting functions |
| 08/17/2011 | CN101646416B Composition for external application to skin |
| 08/17/2011 | CN101642576B Polyethylene glycol-modified product of KGF-2 and preparation method thereof |
| 08/17/2011 | CN101406669B Chinese patent medicine for treating comedo and acne |
| 08/17/2011 | CN101406579B Novel use of pinellia |
| 08/17/2011 | CN101336991B Medicine for treating gynaecologic pruritus vulvae and colpitis |
| 08/17/2011 | CN101274037B Detection method of composition for curing skin pruritus |
| 08/16/2011 | US7999109 CCR9 inhibitors and methods of use thereof |
| 08/16/2011 | US7998986 Heterocyclic compounds, in particular N-substituted pyridones for modulating the activity of nuclear receptors |
| 08/16/2011 | US7998972 1H-imidazo[4,5-c]quinoline derivatives in the treatment of protein kinase dependent diseases |
| 08/16/2011 | US7998954 Pyrimidodiazepinone derivative |
| 08/16/2011 | US7998946 Regulators of the hedgehog pathway, compositions and uses related thereto |
| 08/16/2011 | US7998933 Process for treating the skin comprising applying to the skin at least one composition comprising at least one N-aminoacylamide |
| 08/16/2011 | US7998931 Vascular endothelial cell growth factor antagonists and uses thereof |
| 08/16/2011 | US7998922 Process for treating fibroses with biocompatible polymer |
| 08/16/2011 | US7998493 Hesperidin or Hesperidin methyl chalcone; enzyme ACE (angiotensin converting enzyme) inhibitor dipeptide, an esterified oligopeptide; treat the visible signs of ageing and fatigue |
| 08/16/2011 | US7998474 Methods for treating an inflammatory disease of the bowel |
| 08/16/2011 | CA2507716C Novel adaptor protein that binds to mammalian toll-like receptor 3, and gene thereof |
| 08/16/2011 | CA2496731C Novel benzonaphthyridines |
| 08/16/2011 | CA2487095C Elongase genes and uses thereof |
| 08/16/2011 | CA2467773C Acyloxymethyl esters of c4-16 n-alkane-dicarboxylic acids for the treatment of acne and other related skin disorders |
| 08/16/2011 | CA2458009C Piperazinone compounds as anti-tumor and anti-cancer agents and methods of treatment |
| 08/16/2011 | CA2456648C Human antibodies specific for interleukin 15 (il-15) |
| 08/16/2011 | CA2386960C Method for preparing a composition by mother-of-pearl extraction, comprising the mother-of-pearl integral components, composition obtained by said method and it's use in cosmetic and dermatology |
| 08/16/2011 | CA2382941C Use of leptin in inhibition of endothelial cell proliferation |
| 08/12/2011 | DE202010007074U1 Neue Darreichungsformen für Cineol New forms of cineole |
| 08/11/2011 | WO2011097617A2 Compositions and methods for reducing appearance of under-eye dark circles |
| 08/11/2011 | WO2011097549A2 Treatment skin disorders |
| 08/11/2011 | WO2011097546A2 Topical antibiotic formulations |
| 08/11/2011 | WO2011097347A2 Bismuth-thiols as antiseptics for biomedical uses, including treatment of bacterial biofilms and other uses |
| 08/11/2011 | WO2011097221A2 Methods of promoting tissue growth and tissue regeneration |
| 08/11/2011 | WO2011097081A2 Methods and compositions for oxygenation of skin to treat skin disorders |
| 08/11/2011 | WO2011096688A2 Composition for improving scalp and hair health comprising a dibenzo-p-dioxin derivative |
| 08/11/2011 | WO2011096628A1 Method for preparing uv screening nontoxic extract from red algae, and nontoxic sunscreen using same |
| 08/11/2011 | WO2011096490A1 Imidazopyridin-2-one derivative |
| 08/11/2011 | WO2011096484A1 Read through inducer, and therapeutic agent for nonsense-mutation-type genetic diseases |
| 08/11/2011 | WO2011096461A1 Quinoline derivative |
| 08/11/2011 | WO2011096380A1 Salacia extract with reduced polyphenol content |
| 08/11/2011 | WO2011096377A1 Pyrrole compound |
| 08/11/2011 | WO2011095938A1 Liposomes containing prostaglandin e1 (pge1), formulations containing them and their use |
| 08/11/2011 | WO2011095764A2 Antimicrobial compounds |
| 08/11/2011 | WO2011095705A2 Novel caspase-14 activator peptides and compositions comprising said peptides |
| 08/11/2011 | WO2011034328A3 Composition including chlorophyll a as an active ingredient for preventing and treating th2-mediated immunological diseases |
| 08/11/2011 | US20110196502 Methods of Using Water-Soluble Inorganic Compounds for Implants |
| 08/11/2011 | US20110196128 Murine zcytor17 ligand polynucleotides |
| 08/11/2011 | US20110196040 Skin Penetration Enhancing Systems for Polar Drugs |
| 08/11/2011 | US20110196036 Use of betaine |
| 08/11/2011 | US20110196007 Monocyclic cyanoenones and methods of use thereof |
| 08/11/2011 | US20110196004 Crystalline forms of (r) -5-[3-chloro-4-(2,3-dihydroxy-propoxy)-benz [z] ylidene] -2-( [z]-propylimino) -3-0-tolyl-thiazolidin-4-one |
| 08/11/2011 | US20110196002 Diacylglycerol acyltransferase inhibitors |
| 08/11/2011 | US20110195992 New compounds ii |
| 08/11/2011 | US20110195974 Methods of treating inflammatory conditions with adrenergic antagonists |
| 08/11/2011 | US20110195973 Cyclic substituted pyrazinoylguanidine sodium channel blockers possessing beta agonist activity |
| 08/11/2011 | US20110195967 2-aryl-acetic acids, their derivatives and pharmaceutical compositions containing them |
| 08/11/2011 | US20110195965 Tetrahydro- and dihydroquinazolinones |
| 08/11/2011 | US20110195959 Compositions And Methods Relating To Novel Compounds And Targets Thereof |
| 08/11/2011 | US20110195941 Methods of Use To Orally and Topically Treat Acne and Other Skin Conditions By Administering a 19-NOR Containing Vitamin D Analog With or Without a Retinoid |
| 08/11/2011 | US20110195919 Combination therapy for acne vulgaris comprising administration of adapalene 0.3% gel and clindamycin/benzoyl peroxide gel |
| 08/11/2011 | US20110195900 Peptidic pth receptor agonists |
| 08/11/2011 | US20110195893 Use of apolipoproteins to decrease inflammation |
| 08/11/2011 | US20110195137 Dermo-cosmetic composition for pets |
| 08/11/2011 | US20110195115 Hydrophilic amino acid-containing preparation having improved taste |
| 08/11/2011 | US20110195112 Use of plant-derived recombinant growth factors in skin care |
| 08/11/2011 | US20110195103 Cosmetic or dermopharmaceutical composition containing pseudoalteromonas ferment extract |
| 08/11/2011 | US20110195102 Peptides useful in the treatment and/or care of skin, mucous membranes, scalp and/or hair and their use in cosmetic or pharmaceutical compositions |
| 08/11/2011 | US20110195077 Methods and compositions using fgf23 fusion ppolypeptides |
| 08/11/2011 | US20110195076 Therapeutic agent |
| 08/11/2011 | US20110195067 POLYMERIC IMMUNOGLOBULIN FUSION PROTEINS THAT TARGET LOW AFFINITY FCy RECEPTORS |
| 08/11/2011 | US20110195039 Hair building solid agent |
| 08/11/2011 | US20110195035 Ester Compounds For Use In Personal Care Products |
| 08/11/2011 | US20110195023 Internalizing Anti-CD74 Antibodies and Methods of Use |
| 08/11/2011 | US20110195022 Cd20 antibodies and uses thereof |
| 08/11/2011 | CA2788730A1 Read through inducer, and therapeutic agent for nonsense-mutation-type genetic diseases |
| 08/11/2011 | CA2788684A1 Treatment skin disorders |
| 08/11/2011 | CA2788669A1 Bismuth-thiols as antiseptics for biomedical uses, including treatment of bacterial biofilms and other uses |
| 08/11/2011 | CA2788569A1 Antimicrobial compounds |
| 08/11/2011 | CA2788115A1 Compositions and methods for reducing appearance of under-eye dark circles |
| 08/11/2011 | CA2787725A1 Liposomes containing prostaglandin e1 (pge1), formulations containing them and their use |
| 08/10/2011 | EP2354134A1 2h-chromene compound and derivative thereof |
| 08/10/2011 | EP2353607A1 Use of disintegrin domain of an adamalysin for the treatment of psoriasis |
| 08/10/2011 | EP2353547A1 Agent for regenerating tympanic membrane or external auditory canal |
| 08/10/2011 | EP2352493A1 Therapeutic, dietary, or cosmetic use of compounds with specific anti-apoptotic activity toward caspase-3, and compositions containing these compounds |
| 08/10/2011 | EP2352488A1 Oxidatitive photoactivated skin rejeuvenation composition comprising hyaluronic acid, glucosamine, or allantoin |
| 08/10/2011 | EP2352487A1 Combination of lycopene, polyphenol, and vitamins for the care of keratin material |